Comparison between enzyme-linked immunosorbent assay and indirect immunofluorescence for detection of antineutrophil cytoplasmic antibodies
- PMID: 31994608
- PMCID: PMC6980292
- DOI: 10.31744/einstein_journal/2020AO5132
Comparison between enzyme-linked immunosorbent assay and indirect immunofluorescence for detection of antineutrophil cytoplasmic antibodies
Abstract
Objective: To evaluate the performance of enzyme-linked immunosorbent assay and indirect immunofluorescence methods for the detection of antineutrophil cytoplasmic antibodies in a routine clinical laboratory setting.
Methods: A total of 227 samples were tested by indirect immunofluorescence and enzyme-linked immunosorbent assay with antigen specificity for antiproteinase 3 and antimyeloperoxidase. The proportions of positive samples were compared by McNemar hypotheses and agreement was described by Cohen's Kappa coefficient.
Results: The agreement of the tests was 96.5%, and the Kappa coefficient obtained was 0.70 (95%CI: 0.50-0.90; p<0.001). Considering indirect immunofluorescence as the gold standard, the sensitivity of the enzyme-linked immunosorbent assay was 0.62 and the specificity was 0.99, with diagnostic accuracy in 96% of cases. Some samples were negative in enzyme-linked immunosorbent assay and positive in indirect immunofluorescence. This situation occurred in all immunofluorescence patterns, but particularly in atypical patterns. Two samples with antiproteinase 3 positivity were considered negative in indirect immunofluorescence.
Conclusion: The enzyme-linked immunosorbent assay had high specificity but lower sensitivity. The performance of indirect immunofluorescence increases diagnostic sensitivity, while the search for antiproteinase 3 by enzyme-linked immunosorbent assay may also add diagnostic power.
Objetivo: Avaliar o desempenho das metodologias de ensaio imunoenzimático e imunofluorescência indireta para a detecção de anticorpos anticitoplasma de neutrófilos em um contexto de laboratório clínico de rotina.
Métodos: Foram testadas 227 amostras pelas metodologias de imunofluorescência indireta e ensaio imunoenzimático com especificidades para anticorpos antiproteinase-3 e antimieloperoxidase. As proporções de amostras positivas foram comparadas por hipóteses de McNemar, e a concordância foi descrita pelo coeficiente Kappa de Cohen.
Resultados: A concordância dos testes foi 96,5%, e o coeficiente Kappa obtido foi 0,70 (IC95%: 0,50-0,90; p<0,001). Utilizando a imunofluorescência indireta como padrão-ouro, a sensibilidade do ensaio imunoenzimático foi de 0,62 e a especificidade, 0,99, com acurácia diagnóstica em 96% dos casos. Algumas amostras apresentaram resultados negativos por ensaio imunoenzimático e positivos por imunofluorescência. Isso ocorreu em amostras com vários padrões de fluorescência, mas particularmente nos casos com padrões atípicos. Duas amostras com positividade antiproteinase 3 foram consideradas negativas por imunofluorescência.
Conclusão: Os métodos de ensaio imunoenzimático tiveram alta especificidade, mas sensibilidade inferior. A realização da imunofluorescência indireta aumenta a sensibilidade diagnóstica, ao mesmo tempo que a pesquisa de antiproteinase 3 por ensaio imunoenzimático também pode agregar poder diagnóstico.
Conflict of interest statement
Conflict of interest: none.
Figures






Similar articles
-
Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease.Ann Intern Med. 1997 Jun 1;126(11):866-73. doi: 10.7326/0003-4819-126-11-199706010-00003. Ann Intern Med. 1997. PMID: 9163287 Clinical Trial.
-
Comparison of a multiplex, bead-based fluorescent assay and immunofluorescence methods for the detection of ANA and ANCA autoantibodies in human serum.J Immunol Methods. 2006 Apr 20;311(1-2):189-97. doi: 10.1016/j.jim.2006.02.004. Epub 2006 Mar 3. J Immunol Methods. 2006. PMID: 16554066
-
Antineutrophil cytoplasm antibody: positivity and clinical correlation.Reumatol Clin. 2015 Jan-Feb;11(1):17-21. doi: 10.1016/j.reuma.2014.02.010. Epub 2014 Jun 7. Reumatol Clin. 2015. PMID: 24913965 Clinical Trial. English, Spanish.
-
Clinical value of antineutrophil cytoplasmic antibodies.Curr Rheumatol Rep. 2000 Oct;2(5):383-9. doi: 10.1007/s11926-000-0037-3. Curr Rheumatol Rep. 2000. PMID: 11123087 Review.
-
Testing and reporting antineutrophil cytoplasmic antibodies (ANCA) in treated vasculitis and non-vasculitic disease.J Immunol Methods. 2018 Jul;458:1-7. doi: 10.1016/j.jim.2018.02.016. Epub 2018 Feb 24. J Immunol Methods. 2018. PMID: 29486145 Review.
Cited by
-
A Comparative Evaluation of Antigen-Specific Sandwich Immunoassay and Indirect Immunofluorescence Assay (IIF) in Detecting Antineutrophil Cytoplasmic Antibodies: Are We Ready to Replace IIF with ELISA as the Primary Screening Method?J Lab Physicians. 2021 Sep;13(3):286-290. doi: 10.1055/s-0041-1731945. Epub 2021 Jul 9. J Lab Physicians. 2021. PMID: 34602797 Free PMC article.
-
Effect of transcranial magnetic stimulation on treatment effect and immune function.Saudi J Biol Sci. 2022 Jan;29(1):379-384. doi: 10.1016/j.sjbs.2021.08.104. Epub 2021 Sep 6. Saudi J Biol Sci. 2022. PMID: 35002433 Free PMC article.
-
Detection of IgG Anti-Giardia duodenalis Antibodies in Sera by Indirect Immunofluorescence and Western Blotting Assays.Acta Parasitol. 2024 Mar;69(1):351-357. doi: 10.1007/s11686-023-00753-3. Epub 2023 Dec 14. Acta Parasitol. 2024. PMID: 38095798
References
-
- 2. McKinney EF, Willcocks LC, Broecker V, Smith KG. The immunopathology of ANCA-associated vasculitis. Semin Immunopathol. 2014;36(4):461-78. Review. - PMC - PubMed
- McKinney EF, Willcocks LC, Broecker V, Smith KG. The immunopathology of ANCA-associated vasculitis. Semin Immunopathol. 2014;36(4):461–478. Review. - PMC - PubMed
-
- 3. Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, et al. Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides. Front Immunol. 2018;9:680. Review. - PMC - PubMed
- Lamprecht P, Kerstein A, Klapa S, Schinke S, Karsten CM, Yu X, et al. Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides. 680Front Immunol. 2018;9 Review. - PMC - PubMed
-
- 4. Suwanchote S, Rachayon M, Rodsaward P, Wongpiyabovorn J, Deekajorndech T, Wright HL, et al. Anti-neutrophil cytoplasmic antibodies and their clinical significance. Clin Rheumatol. 2018;37(4):875-84. Review. - PubMed
- Suwanchote S, Rachayon M, Rodsaward P, Wongpiyabovorn J, Deekajorndech T, Wright HL, et al. Anti-neutrophil cytoplasmic antibodies and their clinical significance. Clin Rheumatol. 2018;37(4):875–884. Review. - PubMed
-
- 5. Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 2000;57(3):846-62. Review. - PubMed
- Savige J, Davies D, Falk RJ, Jennette JC, Wiik A. Antineutrophil cytoplasmic antibodies and associated diseases: a review of the clinical and laboratory features. Kidney Int. 2000;57(3):846–862. Review. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources